🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Overweight and Obese Volunteers

A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers NCT07539415Phase 11 site📍 Seoul Daewoong Pharmaceutical Co. LTD. · Tests: DWRX5003, DWC202502, DWC202503, DWRX5003P Evaluate LAE102 in Healthy and Overweight/Obese Subjects NCT06493084Phase 11 site📍 Shanghai Laekna Limited · Tests: LAE102 intravenous administration, placebo intravenous administration, LAE102 subcutaneous administration, placebo subc… A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus NCT06700538Phase 1, Phase 215 sites📍 Camberwell📍 Charlestown📍 Maroochydore Arrowhead Pharmaceuticals · Tests: ARO-INHBE, Placebo, Tirzepatide A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity NCT07578584Phase 11 site📍 Neuss Novo Nordisk A/S · Tests: NNC0497-0040, Placebo Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose NCT06223555NA1 site📍 Phoenix National Institute of Diabetes and Digestive and Kidney Dis… · Tests: Fixed Mixed Meal Test, Adjusted Mixed Meal Test Taste Physiology in Obese Volunteers Before and After Bariatric Surgery NCT02902198NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: Placebo, Glucose, Monosodium glutamate, Quinine Alpelisib Challenge Test (ACT) NCT07778524Phase 11 site📍 New York Columbia University · Tests: Alpelisib 300 mg, Alpelisib Challenge Test (ACT): Mixed Meal Tolerance Test (MMTT) after taking alpelisib, Hyperglycemi… Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers NCT07184502Phase 12 sites📍 Brisbane📍 Melbourne Beijing QL Biopharmaceutical Co.,Ltd · Tests: ZT003 - Part1 (Single ascending dose ), ZT003 - Part 2(Multiple ascending dose ) Diabetes and Heart Disease Risk in Blacks NCT00001853n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers. NCT06891287Phase 11 site📍 Melbourne RANI Therapeutics · Tests: RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity, PG-102, Placebo A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus NCT06937203Phase 1, Phase 28 sites📍 Morayfield📍 Nedlands📍 Grafton Arrowhead Pharmaceuticals · Tests: ARO-ALK7, Placebo A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection NCT06934408Phase 11 site📍 Hefei Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-5817 Injection, HRS-5817 Injection Placebo New Heart Imaging Techniques to Evaluate Possible Heart Disease NCT01399385NA1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… · Tests: MR Imaging Techniques - 1, MR Imaging Techniques - 2, MR Imaging Techniques - 3, MR Imaging Techniques - 4 The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure NCT05545306NA1 site📍 Phoenix National Institute of Diabetes and Digestive and Kidney Dis… · Tests: +200% of dietary requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat, fasting, -50% of… Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease NCT04873258n/a1 site📍 London Richmond Research Institute · Tests: Bioimpedence Vector Analysis A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use NCT07446439Phase 310 sites📍 Los Angeles📍 San Diego📍 San Jose Vanda Pharmaceuticals · Tests: Tradipitant, Placebo Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity NCT07245771Phase 1, Phase 21 site📍 Melbourne Ikaria Bioscience Pty Ltd · Tests: RN3161, Placebo Control, Tirzepatide Physical and Behavioral Traits of Overweight and Obese Adults NCT00428987n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Children s Growth and Behavior Study NCT02390765n/a1 site📍 Bethesda Eunice Kennedy Shriver National Institute of Child Health a…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy